Vandria’s 2nd Series A close brings the total round to $30.7M to Progress the Mitophagy Inducer VNA-318 into CNS Clinical Development



Comments are closed.

Podium Data Raises $9.5 Million Series A Financing Round
Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline
Eargo Is The Hearing Aid Of The Future
Paradromics is one of several companies working on technology to help people interact with the outside world using their mind.